Development Pipeline Our pipeline is anchored by EFX, a potential best-in-class treatment, if approved, for MASH. PreCli. Preclinical Ph1 Phase 1 Ph2 Phase 2 Phase 3 Ph3 Program Phase Efruxifermin (EFX) Efruxifermin (EFX) MASH PH3 Efruxifermin (EFX) Efruxifermin (EFX) MASH Cirrhosis PH2 Research Programs Research Programs Undisclosed Indications Pre-C EFX is a multi-modal investigational drug that holistically confronts MASH. Learn About EFX